section name header

Information

Pharmacologic Profile

General Use

The goal of antiretroviral therapy in the management of HIV infection is to improve CD4 cell counts and viral load. If accomplished, this generally results in slowed progression of the disease, improved quality of life, and opportunistic infections. Perinatal use of agents also prevents transmission of the virus to the fetus. Post-exposure and pre-exposure prophylaxis with certain antiretrovirals is also recommended.

General Action and Information

Because of the rapid emergence of resistance and toxicities of individual agents, HIV infection is almost always managed by a combination of agents. Selections and doses are based on individual toxicities, underlying organ system disease, concurrent drug therapy, and severity of illness.

Contraindications

Hypersensitivity. Because of highly varying toxicities among agents, see individual monographs for more specific information.

Precautions

Many agents require modification for renal impairment. Protease inhibitors may cause hyperglycemia and hyperlipidemia and should be used cautiously in patients with diabetes and patients at increased risk for cardiovascular disease. Hemophiliacs may also be at risk of bleeding when taking protease inhibitors. See individual monographs for specific information.

Interactions

There are many significant and potentially serious drug-drug interactions among the antiretrovirals. They are affected by drugs that alter metabolism; some agents themselves affect metabolism. See individual agents.

Nursing Implications

Assessment

Potential Nursing Diagnoses

Implementation

Patient/Family Teaching

Evaluation/Desired Outcomes


Antiretrovirals included in Davis's Drug Guide for Nurses